Benchmark Downgrades Emergent BioSolutions (EBS) to Hold

November 8, 2021 4:28 AM EST Send to a Friend
Benchmark analyst Robert Wasserman downgraded Emergent BioSolutions (NYSE: EBS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login